Morningstar5h
Merck KGaA's Cell-Tumor Drug Gets Positive Results in Late-Stage Trial
The drug is being developed by the Chinese biotech Abbisko Therapeutics Co. Merck KGaA holds commercial license for Pimicotinib in Chinese mainland, Hong Kong, Macau, and Taiwan, it said.
Business Wire5h
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
with very low rates of discontinuation due to treatment-related adverse events Pimicotinib is being developed by Abbisko Therapeutics Co., Ltd.; Merck holds commercial license for pimicotinib in ...
TMCnet5m
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based ...
The Pharma Letter15h
Merck's Keytruda and Citius' Lymphir combo trial shows promising results
Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...
Le Lézard14h
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Joseph Eid, M.D. as Executive Vice ...
Abbisko: Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
The MANEUVER study met the primary endpoint with an objective response rate (ORR) at week 25 of 54.0% compared with 3.2% for placebo (p- Statistically significant ...
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its ...
Big News Network.com3h
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
Global Head of Bio4C Commercial, Merck, Singapore * Rajesh Krishnamurthy, Chief Executive Officer, Laurus Bio * Tine Rorvik, ...
Koneksa Appoints Eric Luthi as Chief Business Officer
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the appointment of Eric Luthi as Chief Business Officer. In this newly created role, Mr. Luthi ...
manilatimes23h
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
Earlier in his career, he served as CFO at multiple publicly-traded biotech companies including Sirna Therapeutics, a genetic ...
Le Lézard34m
TheracosBio is a Proud Sponsor of the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
"In the third quarter, we delivered strong commercial results, maintained financial discipline, and... Trinity Capital Inc. ("Trinity"), a leading provider of diversified financial solutions to growth ...
After Montgomery County debut, more Dill Dinkers indoor pickleball sites planned in region
The two new facilities add a combined 23 indoor pickleball courts as operators continue to grow in the market.